Pharma stories

Filter topic:
Filter sector:

Join our mailing list

Achieving commercial excellence in the new normal

It’s clear that ways of working and travel aren’t going to go back to where they were. We need more permanent solutions if we’re going to have the impact and results we need.

4 minute read —

Defining what On-Demand means for learning

The shift to on-demand learning expectations has accelerated. Yet eLearning only makes a real difference to an organization when it aligns with the development objective.

Where will consumers buy their (over-the-counter) drugs in future?

An unprecedented change is currently taking place in the sale of pharmaceutical products, pointing to the influence of new competition with the existing pharmacy structure.

Are diagnostics the solution to growing healthcare needs?

Diagnostics are growing in importance, with new generations of genetic tests emerging. Can these improve both clinical and economic outcomes?

6 minute read —

Real-time digital monitoring tools in Pharma; the lessons of the SMART insulin pens

The ability of digital health enablers to keep patients connected with their healthcare providers has never been as highly valued, and we believe the connectivity offered by digital devices such as the S-Pen might become the most important driver of use in the future.

8 minute read —

Closing the gap: the rise of prescription digital therapeutics

Can digital health and Prescription Digital Therapeutics finally close the gap between clinical trials and everyday clinical practice? Here's how we expect PDTs to become a far more common part of the solution and a genuine opportunity to close the gap.

8 minute read —

Leveraging a portfolio with purpose: Vertex in cystic fibrosis

When we look across different industries, we often see how brands, portfolios and companies with a clear purpose tend to do better than others. It’s harder to talk purpose in Pharma though, as purpose is inherent in the product, but the Vertex story is a compelling one that we keep coming back to

5 minute read —

Crossing the Pharma Chasm. Why do Pharma launches fail?

In the last decade, the industry has established launch excellence teams to address this vital stage in a brand’s lifecycle and invested significantly to improve performance. Despite a presumed focus on the basics, brands are generally not improving their sales curve beyond that achieved at 6 months. Why?

5 minute read —

COVID-19 is driving digital transformation faster than any previous stimulus

If digital is thought of at just a tactical level, you might miss out on the strategic brand options that could have enabled you to respond faster, quicker, better to COVID-19. Here are those options.

4 minute read —

The power of insight and partnerships in defining portfolio strategy in Healthcare

Depth of customer understanding and using insight will enable companies to define rapidly how experiences and customer journeys are changing.

Anticipating the new drivers of behaviour in healthcare

Like others, we’ve been closely watching the unprecedented rate of change we have seen in healthcare markets recently, driven by responses to the COVID-19 pandemic. Here are the priorities and areas of focus for leaders navigating out of lockdown.

2 minute read —

Developing a customer-centric Pharma account management culture

With so many talking about being customer-centric in Pharma account management teams, why are so few delivering it?